POICX
Price
$11.45
Change
-$0.01 (-0.09%)
Updated
Oct 17 closing price
Net Assets
626.72M
RLBCX
Price
$38.75
Change
+$0.04 (+0.10%)
Updated
Oct 17 closing price
Net Assets
265.37B
Interact to see
Advertisement

POICX vs RLBCX

Header iconPOICX vs RLBCX Comparison
Open Charts POICX vs RLBCXBanner chart's image
Virtus Tactical Allocation C
Price$11.45
Change-$0.01 (-0.09%)
VolumeN/A
Net Assets626.72M
American Funds American Balanced R3
Price$38.75
Change+$0.04 (+0.10%)
VolumeN/A
Net Assets265.37B
POICX vs RLBCX Comparison Chart in %
View a ticker or compare two or three
VS
POICX vs. RLBCX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is POICX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 265B vs. POICX (627M). RLBCX pays higher dividends than POICX: RLBCX (1.49) vs POICX (0.90). POICX was incepted earlier than RLBCX: POICX (26 years) vs RLBCX (23 years). POICX (1.87) is less costly to investors than RLBCX (0.89). RLBCX is a more actively managed with annual turnover of: 44.00 vs. POICX (37.00). RLBCX has a lower initial minimum investment than POICX: RLBCX (250) vs POICX (2500). RLBCX annual gain was more profitable for investors over the last year : 8.34 vs. POICX (-5.99). RLBCX return over 5 years is better than : 40.24 vs. POICX (-9.16).
POICXRLBCXPOICX / RLBCX
Total Expense Ratio1.750.89197%
Annual Report Gross Expense Ratio1.870.89210%
Fund Existence26 years23 years-
Gain YTD6.21814.36443%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets627M265B0%
Annual Yield % from dividends0.901.4961%
Returns for 1 year-5.998.34-72%
Returns for 3 years26.8549.2655%
Returns for 5 years-9.1640.24-23%
Returns for 10 years33.8872.1847%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PBM3.520.07
+2.03%
Psyence Biomedical Ltd
CVGW23.810.14
+0.59%
Calavo Growers
SWK67.85-0.06
-0.09%
Stanley Black & Decker
IQ2.03-0.03
-1.46%
iQIYI
PMVP1.40-0.04
-2.78%
PMV Pharmaceuticals